Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Berti

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2008
Dedifferentiated thyroid cancer: a therapeutic challengeAlessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
European Journal of Endocrinology|August 7, 2004
Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumorsGiampaolo Bernini, Angelica Moretti, Vincenzo Fontana, et al.
European Journal of Endocrinology|May 23, 2008
Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodellingGiampaolo Bernini, Fabio Galetta, Ferdinando Franzoni, et al.
Human Pathology|June 29, 2007
Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivityLiborio Torregrossa, Pinuccia Faviana, Tiziano Camacci, et al.
European Journal of Endocrinology|June 28, 2008
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspirationAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2010
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological featuresAgnese Proietti, Riccardo Giannini, Clara Ugolini, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 casesFulvio Basolo, Liborio Torregrossa, Riccardo Giannini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinomaRiccardo Giannini, Clara Ugolini, Cristiana Lupi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinomaCristiana Lupi, Riccardo Giannini, Clara Ugolini, et al.
Clinical Endocrinology|January 25, 2006
Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical managementFilomena Cetani, Elena Pardi, Elena Ambrogini, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2008
Dedifferentiated thyroid cancer: a therapeutic challengeAlessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari, et al.
European Journal of Endocrinology|August 7, 2004
Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumorsGiampaolo Bernini, Angelica Moretti, Vincenzo Fontana, et al.
European Journal of Endocrinology|May 23, 2008
Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodellingGiampaolo Bernini, Fabio Galetta, Ferdinando Franzoni, et al.
Human Pathology|June 29, 2007
Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivityLiborio Torregrossa, Pinuccia Faviana, Tiziano Camacci, et al.
European Journal of Endocrinology|June 28, 2008
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspirationAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2010
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological featuresAgnese Proietti, Riccardo Giannini, Clara Ugolini, et al.
The Journal of Clinical Endocrinology and Metabolism|July 16, 2010
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 casesFulvio Basolo, Liborio Torregrossa, Riccardo Giannini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinomaRiccardo Giannini, Clara Ugolini, Cristiana Lupi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinomaCristiana Lupi, Riccardo Giannini, Clara Ugolini, et al.
Clinical Endocrinology|January 25, 2006
Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical managementFilomena Cetani, Elena Pardi, Elena Ambrogini, et al.
Pageof 6